Context Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CNTX Key Statistics
Stock Snapshot
As of today, Context Therapeutics(CNTX) shares are valued at $0.19. The company's market cap stands at 17.56M, with a P/E ratio of -0.39.
During the trading session on 2026-11-01, Context Therapeutics(CNTX) shares reached a daily high of $0.21 and a low of $0.19. At a current price of $0.19, the stock is +0.2% higher than the low and still -10.0% under the high.
Trading volume for Context Therapeutics(CNTX) stock has reached 1.01M, versus its average volume of 1.21M.
The stock's 52-week range extends from a low of $0.19 to a high of $3.62.
The stock's 52-week range extends from a low of $0.19 to a high of $3.62.
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.